"Anxiety about when and where symptoms will occur can also lead to avoidance of social activities, especially ones in which food is the focus, or when bathrooms may not be readily available
Results announced in December 2025 confirmed the Phase 2 findings at a longer timepoint (Lilly Press Release, Dec 2025): The 28.7% weight loss at 68 weeks exceeds both semaglutide (~15% in STEP trials) and tirzepatide (~22.5% in SURMOUNT trials) at similar timepoints
others had modest effects on weight loss
Cui H, Wang N, Li H, Bian Y, Wen W, Kong X, et al
Through our online pharmacy, consult with licensed healthcare professionals who can evaluate your condition and issue a prescription if appropriate